Anti-inflammatory effects of the novel phosphodiesterase IV inhibitor RP 73401.

Suppr

超能文献

作者信息

Karlsson J A, Souness J, Webber S, Pollock K, Raeburn D

机构信息

Rhône-Poulenc Rorer Ltd., Dagenham Research Centre, Dagenham, UK.

出版信息

Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):425-6. doi: 10.1159/000237066.

DOI:10.1159/000237066

PMID:7613200

Abstract

摘要

相似文献

Anti-inflammatory effects of the novel phosphodiesterase IV inhibitor RP 73401.

Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):425-6. doi: 10.1159/000237066.

Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram.环磷酸腺苷特异性磷酸二酯酶强效选择性抑制剂RP 73401对嗜酸性粒细胞功能的抑制作用：与咯利普兰的比较

Br J Pharmacol. 1995 May;115(1):39-46. doi: 10.1111/j.1476-5381.1995.tb16317.x.

Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor.新型选择性磷酸二酯酶IV型抑制剂RP 73401的抗炎及支气管扩张特性

Br J Pharmacol. 1994 Dec;113(4):1423-31. doi: 10.1111/j.1476-5381.1994.tb17156.x.

In vitro pharmacology of the novel phosphodiesterase type 4 inhibitor, CP-80633.新型磷酸二酯酶4抑制剂CP-80633的体外药理学

J Pharmacol Exp Ther. 1996 Sep;278(3):1356-61.

The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.新型磷酸二酯酶4立体选择性抑制剂CDP840对抗抗原诱导的嗜酸性粒细胞增多和支气管收缩作用

Br J Pharmacol. 1996 Jul;118(5):1183-91. doi: 10.1111/j.1476-5381.1996.tb15522.x.

Pulmonary antiallergic and antiinflammatory effects of a novel, orally-active phosphodiesterase IV inhibitor (WAY-127093B) in guinea pigs and rats.

Inflamm Res. 1995 Aug;44 Suppl 2:S172-3. doi: 10.1007/BF01778317.

Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response.选择性磷酸二酯酶IV型抑制剂咯利普兰对炎症反应的液体和细胞阶段的影响。

Inflammation. 1993 Jun;17(3):333-44. doi: 10.1007/BF00918994.

Selective type IV phosphodiesterase inhibitors as antiasthmatic agents. The syntheses and biological activities of 3-(cyclopentyloxy)-4-methoxybenzamides and analogues.作为抗哮喘药物的选择性IV型磷酸二酯酶抑制剂。3-(环戊氧基)-4-甲氧基苯甲酰胺及其类似物的合成与生物活性。

J Med Chem. 1994 May 27;37(11):1696-703. doi: 10.1021/jm00037a021.

Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.非选择性和选择性磷酸二酯酶抑制剂对人嗜酸性粒细胞功能的不同影响。

Br J Pharmacol. 1995 Feb;114(4):821-31. doi: 10.1111/j.1476-5381.1995.tb13278.x.

Multiplicity within cyclic nucleotide phosphodiesterases.环核苷酸磷酸二酯酶的多样性

Biochem Soc Trans. 1996 Nov;24(4):1005-9. doi: 10.1042/bst0241005.

引用本文的文献

Cross-talk between PKA-Cβ and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi.蛋白激酶A催化亚基β（PKA-Cβ）与p65之间的相互作用介导罗氟司特和肺炎衣原体协同诱导磷酸二酯酶4B（PDE4B）。

Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):E1800-9. doi: 10.1073/pnas.1418716112. Epub 2015 Mar 23.

Effects of piclamilast, a selective phosphodiesterase-4 inhibitor, on oxidative burst of sputum cells from mild asthmatics and stable COPD patients.

Lung. 2004;182(6):369-77. doi: 10.1007/s00408-004-2518-z.

Phosphodiesterase isoenzyme families in human osteoarthritis chondrocytes--functional importance of phosphodiesterase 4.人类骨关节炎软骨细胞中的磷酸二酯酶同工酶家族——磷酸二酯酶4的功能重要性

Br J Pharmacol. 2002 Feb;135(3):609-18. doi: 10.1038/sj.bjp.0704480.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验